PMC:7105881 / 51255-51464 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1603","span":{"begin":64,"end":72},"obj":"Species"}],"attributes":[{"id":"A1603","pred":"tao:has_database_id","subj":"1603","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The above studies indicate that protein lengths to be chosen as MERS-CoV subunit vaccines and/or structure-based vaccine design can impact on the immunogenicity and/or protection of RBD-based subunit vaccines."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T293","span":{"begin":32,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A293","pred":"fma_id","subj":"T293","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"The above studies indicate that protein lengths to be chosen as MERS-CoV subunit vaccines and/or structure-based vaccine design can impact on the immunogenicity and/or protection of RBD-based subunit vaccines."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9112","span":{"begin":32,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A15247","pred":"chebi_id","subj":"T9112","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"The above studies indicate that protein lengths to be chosen as MERS-CoV subunit vaccines and/or structure-based vaccine design can impact on the immunogenicity and/or protection of RBD-based subunit vaccines."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T279","span":{"begin":0,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The above studies indicate that protein lengths to be chosen as MERS-CoV subunit vaccines and/or structure-based vaccine design can impact on the immunogenicity and/or protection of RBD-based subunit vaccines."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T819","span":{"begin":64,"end":72},"obj":"SP_9"},{"id":"T820","span":{"begin":113,"end":127},"obj":"BV_26"},{"id":"T821","span":{"begin":146,"end":160},"obj":"BV_15"},{"id":"T80013","span":{"begin":64,"end":72},"obj":"SP_9"},{"id":"T87612","span":{"begin":113,"end":127},"obj":"BV_26"},{"id":"T81328","span":{"begin":146,"end":160},"obj":"BV_15"}],"text":"The above studies indicate that protein lengths to be chosen as MERS-CoV subunit vaccines and/or structure-based vaccine design can impact on the immunogenicity and/or protection of RBD-based subunit vaccines."}